Latest filings (excl ownership)
15-12G
Securities registration termination
22 Mar 24
EFFECT
Notice of effectiveness
15 Mar 24
EFFECT
Notice of effectiveness
15 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Mar 24
POS AM
Prospectus update (post-effective amendment)
12 Mar 24
POS AM
Prospectus update (post-effective amendment)
12 Mar 24
8-K
Completion of Acquisition or Disposition of Assets
12 Mar 24
SC 14D9/A
Tender offer solicitation (amended)
12 Mar 24
SC TO-T/A
Third party tender offer statement (amended)
12 Mar 24
25-NSE
Exchange delisting
12 Mar 24
SC TO-T/A
Third party tender offer statement (amended)
4 Mar 24
SC 14D9/A
Tender offer solicitation (amended)
4 Mar 24
SC 14D9
Tender offer solicitation
12 Feb 24
SC TO-T
Third party tender offer statement
12 Feb 24
SC14D9C
Written communication relating to third party tender offer
9 Feb 24
8-K
Cost Associated with Exit or Disposal Activities
9 Feb 24
SC TO-C
Information about tender offer
30 Jan 24
SC14D9C
Written communication relating to third party tender offer
29 Jan 24
8-K
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
29 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
22 Dec 23
8-K
Material Modifications to Rights of Security Holders
5 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
29 Nov 23
S-8
Registration of securities for employees
7 Nov 23
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
Science 37 Reports Third Quarter 2023 Financial Results
7 Nov 23
DEF 14A
Definitive proxy
27 Oct 23
PRE 14A
Preliminary proxy
3 Oct 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
8-K
Science 37 Reports Second Quarter 2023 Financial Results
8 Aug 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
27 Jun 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Science 37 Reports First Quarter 2023 Financial Results
15 May 23
8-K
Submission of Matters to a Vote of Security Holders
11 May 23
8-K
Departure of Directors or Certain Officers
2 May 23
SC TO-I/A
Issuer tender offer statement (amended)
2 May 23
SC TO-I/A
Issuer tender offer statement (amended)
19 Apr 23
8-K
Departure of Directors or Certain Officers
19 Apr 23
Latest ownership filings
4
Change in insider ownership
14 Mar 24
4
Change in insider ownership
14 Mar 24
3/A
Initial statement of insider ownership (amended)
14 Mar 24
SC 13D/A
THERMO FISHER SCIENTIFIC INC.
14 Mar 24
4
Robert C. Faulkner
13 Mar 24
4
Jeremy Green
13 Mar 24
SC 13D/A
Redmile Group, LLC
13 Mar 24
4
Michael Shipton
12 Mar 24
4
Jonathan Cotliar
12 Mar 24
4
Darcy Forman
12 Mar 24
4
Mike Zaranek
12 Mar 24
4
Christine A Pellizzari
12 Mar 24
4
Autenried Paul von
12 Mar 24
4
Neil Tiwari
12 Mar 24
4
Emily Rollins
12 Mar 24
4
John W Hubbard
12 Mar 24
4
David Coman
12 Mar 24
SC 13D/A
Redmile Group, LLC
31 Jan 24
4
Michael Shipton
10 Oct 23
4
David Coman
15 Aug 23
4
Darcy Forman
15 Aug 23
4
Mike Zaranek
15 Aug 23
4
Jonathan Cotliar
15 Aug 23
4
Christine A Pellizzari
15 Aug 23
4
Christine A Pellizzari
22 May 23
4
Jeremy Green
15 May 23
4
Robert C. Faulkner
15 May 23
4
Troy Bryenton
12 May 23
4
Neil Tiwari
12 May 23
4
Autenried Paul von
12 May 23
4
John W Hubbard
12 May 23
4
Emily Rollins
12 May 23
4
Michael Shipton
12 May 23
3
Troy Bryenton
12 May 23
4
Darcy Forman
2 May 23
4
Jonathan Cotliar
2 May 23
4
David Coman
2 May 23
4
Mike Zaranek
2 May 23
4
Christine A Pellizzari
2 May 23
4
Michael Shipton
15 Mar 23